Simulations Plus Inc
SLP13.030USD
+0.230+1.80%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
262.12MMarktkapitalisierung
36.10KGV TTM
mehr Informationen über Simulations Plus Inc Unternehmen
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Unternehmensinformationen
BörsenkürzelSLP
Name des UnternehmensSimulations Plus Inc
IPO-datumJun 18, 1997
CEOMr. Shawn M. O'Connor
Anzahl der mitarbeiter243
WertpapierartOrdinary Share
GeschäftsjahresendeJun 18
Addresse800 Park Offices Drive, Suite 401
StadtRESEARCH TRIANGLE PARK
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl27709
Telefon16617237723
Websitehttps://www.simulations-plus.com/
BörsenkürzelSLP
IPO-datumJun 18, 1997
CEOMr. Shawn M. O'Connor
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.30M
-0.60%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
9.44K
+9.09%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
6.85K
+12.96%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven Chang
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.30M
-0.60%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
9.44K
+9.09%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
6.85K
+12.96%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Software licenses
13.48M
60.11%
Consulting services
8.95M
39.89%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
16.11M
71.83%
Europe
4.81M
21.42%
Asia
1.51M
6.75%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Software licenses
13.48M
60.11%
Consulting services
8.95M
39.89%
Aktionärsstatistik
Aktualisiert: Fri, Aug 1
Aktualisiert: Fri, Aug 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Woltosz (Walter S)
16.42%
BlackRock Institutional Trust Company, N.A.
11.37%
Conestoga Capital Advisors, LLC
6.37%
The Vanguard Group, Inc.
5.44%
Janus Henderson Investors
4.45%
Other
55.95%
Aktionäre
Aktionäre
Anteil
Woltosz (Walter S)
16.42%
BlackRock Institutional Trust Company, N.A.
11.37%
Conestoga Capital Advisors, LLC
6.37%
The Vanguard Group, Inc.
5.44%
Janus Henderson Investors
4.45%
Other
55.95%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
40.20%
Investment Advisor/Hedge Fund
36.04%
Individual Investor
17.33%
Research Firm
3.35%
Hedge Fund
3.34%
Pension Fund
1.97%
Bank and Trust
1.43%
Venture Capital
0.07%
Family Office
0.04%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
395
19.83M
98.53%
-2.60M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
2023Q2
406
19.53M
98.02%
-1.10M
2023Q1
421
19.42M
97.11%
-1.40M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Woltosz (Walter S)
3.32M
16.53%
-20.00K
-0.60%
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
2.29M
11.38%
-24.85K
-1.07%
Mar 31, 2025
Conestoga Capital Advisors, LLC
2.61M
12.97%
+383.13K
+17.21%
Mar 31, 2025
The Vanguard Group, Inc.
1.10M
5.45%
-47.76K
-4.18%
Mar 31, 2025
Janus Henderson Investors
896.34K
4.46%
+353.44K
+65.10%
Mar 31, 2025
State Street Global Advisors (US)
706.51K
3.51%
-14.51K
-2.01%
Mar 31, 2025
Ranger Investment Management, L.P.
695.00K
3.46%
-7.30K
-1.04%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
475.53K
2.36%
+56.29K
+13.43%
Mar 31, 2025
Kennedy Capital Management LLC
469.30K
2.33%
+180.01K
+62.23%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
422.80K
2.1%
+28.38K
+7.20%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
SPDR FactSet Innovative Technology ETF
0.57%
First Trust Active Factor Small Cap ETF
0.31%
Global X HealthTech ETF
0.3%
Invesco Nasdaq Free Cash Flow Achievers ETF
0.3%
Franklin Exponential Data ETF
0.28%
WisdomTree Artificial Intelligence and Innov Fund
0.22%
Invesco S&P SmallCap Health Care ETF
0.2%
First Trust Multi-Manager Small Cap Opportunities ETF
0.13%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.1%
WisdomTree US SmallCap Quality Growth Fund
0.1%
Mehr Anzeigen
SPDR FactSet Innovative Technology ETF
Anteil0.57%
First Trust Active Factor Small Cap ETF
Anteil0.31%
Global X HealthTech ETF
Anteil0.3%
Invesco Nasdaq Free Cash Flow Achievers ETF
Anteil0.3%
Franklin Exponential Data ETF
Anteil0.28%
WisdomTree Artificial Intelligence and Innov Fund
Anteil0.22%
Invesco S&P SmallCap Health Care ETF
Anteil0.2%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.13%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.1%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.1%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
23.51M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
